Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DYNEX CAPITAL INC (DX)

  • Business News
  • April 20, 2026, 11:59 UTC
  • 3
  • 1 comments

Dynex Capital, Inc. Announces First Quarter 2026 Results

Market reaction Comment Full text

QUIDELORTHO CORP (QDEL)

  • Business News
  • April 20, 2026, 11:56 UTC
  • 3
  • 1 comments

TTP Group Announces the Sale of LEX Diagnostics

Market reaction Comment Full text

SIMULATIONS PLUS, INC. (SLP)

  • Business News
  • April 20, 2026, 11:55 UTC
  • 3
  • 1 comments

Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School

Market reaction Comment Full text

SIGNATURE DEVICES, INC. (SDVI)

  • Business News
  • April 20, 2026, 11:54 UTC
  • 3
  • 1 comments

Net Asset Value(s)

Market reaction Comment Full text

CLAL INSURANCE ENTERPRISES HOLDINGS LTD. (CLIS)

  • Business News
  • April 20, 2026, 11:51 UTC
  • 3
  • 1 comments

Register of shareholders, changes and capital status – conversion into shares of BONDS series 2

Market reaction Comment Full text

Artelo Biosciences Inc. (ARTLW)

  • Business News
  • April 20, 2026, 11:50 UTC
  • 3
  • 1 comments

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

Market reaction Comment Full text

REDCLOUD HOLDINGS PLC (RCT)

  • Business News
  • April 20, 2026, 11:50 UTC
  • 3
  • 1 comments

RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue

Market reaction Comment Full text

Medtronic plc. (MDT)

  • Business News
  • April 20, 2026, 11:50 UTC
  • 3
  • 1 comments

Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease

Market reaction Comment Full text

ARTELO BIOSCIENCES, INC. (ARTL)

  • Business News
  • April 20, 2026, 11:50 UTC
  • 3
  • 1 comments

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

Market reaction Comment Full text

PSYENCE BIOMEDICAL LTD. (PBM)

  • Business News
  • April 20, 2026, 11:42 UTC
  • 3
  • 1 comments

Psyence BioMed Positioned as Worlds only Licensed Pharmaceutical Grade Ibogaine Supplier at Source

Market reaction Comment Full text
  • Previous
  • 1132
  • 1133
  • 1134
  • 1135
  • 1136
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158469)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin